Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2012
10/18/2012US20120263724 Escherichia coli o157:h7 proteins and uses thereof
10/18/2012US20120263720 Novel Therapeutic and Diagnostic Means
10/18/2012US20120263719 Compositions and methods for treating aspergillosis
10/18/2012US20120263715 Topical Methods Of Treating RSV Infections And Related Conditions
10/18/2012US20120263712 Pyrrolidine-1,2-dicarboxamide derivatives
10/18/2012US20120263695 Composition having strains of lactobacillus fermentum
10/18/2012US20120263679 Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
10/18/2012US20120263678 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment
10/18/2012US20120263667 Composition and method for modulating and maintaining vaginal bacterial flora and vaginal acidity
10/18/2012US20120263660 Hair Loss Treatment
10/18/2012US20120263657 Promoting Whole Body Health
10/18/2012US20120263653 Methods and systems for generating nanoparticles
10/18/2012US20120263648 Rna nanoparticles and nanotubes
10/18/2012US20120263644 Treatment and diagnosis of inflammatory disorders and hiv
10/18/2012US20120260922 Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection
10/18/2012CA2833176A1 Chimeric antibacterial polypeptides
10/18/2012CA2833078A1 Treatment of microbial infections
10/18/2012CA2832933A1 Methods for treating bacterial infection
10/18/2012CA2832829A1 Treatment of hepatitis c virus infection with alisporivir
10/18/2012CA2831258A1 Compositions for preventing and/or treating an infection by an hiv-1 virus
10/18/2012CA2830786A1 Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
10/18/2012CA2830689A1 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment
10/17/2012EP2511368A1 Recombinant measles virus useful as bivalent vaccine against measles and nipah virus infection
10/17/2012EP2511367A1 Recombinant measles virus useful as bivalent vaccine against measles and malaria infection
10/17/2012EP2511295A1 Compositions for preventing and/or treating an infection by an HIV-1 virus
10/17/2012EP2511281A1 Acyclic nucleoside phosphonate derivatives and medicine uses thereof
10/17/2012EP2510944A1 Treatment of bacterial infections
10/17/2012EP2510929A1 Methods for treating bacterial infection
10/17/2012EP2510097A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof
10/17/2012EP2509984A1 Fungicidal compounds and methods of their use
10/17/2012EP2509950A1 5-amino- 4-hydroxypentoyl amides
10/17/2012EP2509949A2 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
10/17/2012EP2509622A2 Inhibiting bacterial infection and biofilm formation
10/17/2012EP2509617A1 Arenicin-3 for use in the treatment of urinary tract infections
10/17/2012EP2509615A1 Novel cyclic peptides
10/17/2012EP2509610A1 Compositions for the vaginal and oral administration of lactobacillus and uses thereof
10/17/2012EP2509595A1 Inhibitors of hemopoietic cell kinase (p59-hck) and their use in the treatment of influenza infection
10/17/2012EP2509593A2 Therapeutic use of protein-polymer conjugates
10/17/2012EP2509589A1 Pharmaceutical or veterinary antiviral compositions
10/17/2012EP1631255B1 Drug delivery system
10/17/2012CN102741272A Peptides inhibiting adhesion of aspergillus fumigatus to cornea
10/17/2012CN102741270A Cyclic peptide inhibitors of hepatitis c virus replication
10/17/2012CN102741259A Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
10/17/2012CN102741249A Hetaryl-[1,8]naphthyridine derivatives
10/17/2012CN102741241A Benzimidazole-imidazole derivatives
10/17/2012CN102740872A Methods and compositions for providing protective immunity in the elderly
10/17/2012CN102740861A Compositions and methods for treating hepatitis b virus infection
10/17/2012CN102740858A Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same
10/17/2012CN102740846A Compositions for topical administration
10/17/2012CN102740845A Treatment of microbial infections
10/17/2012CN102735809A Method for determining content of polymer conjugate in Hib conjugate vaccine
10/17/2012CN102732550A Expression of human s1CD80 protein in Pichia pastoris system
10/17/2012CN102732544A A method for expelling a bacillus anthracis virulence large plasmid pXO1
10/17/2012CN102732519A Screening and application of special siRNA of multi-serotype foot and mouth disease virus 3C gene
10/17/2012CN102732510A Method for simultaneously removing bacillus anthracis virulence megaplasmids pXO1 and pXO2
10/17/2012CN102732486A Porcine circovirus type2 strain and application thereof
10/17/2012CN102732474A Compound for inhibiting mycobacterium tuberculosis, screening method and uses thereof
10/17/2012CN102732473A Recombinant salmonella choleraesuis expressing mycoplasma hyopneumoniae p46 protein, preparation method and application thereof
10/17/2012CN102732472A Construction and application of attenuated Salmonella choleraesuis for expressing mycoplasma hyopneumoniae p65 protein
10/17/2012CN102732468A Enterococcus faecalis and broad-spectrum bacterium inhibition function thereof
10/17/2012CN102731660A Preparation and application of GIT fusion protein used for preventing dairy cow mastitis
10/17/2012CN102731652A Preparation method of nanoliposome anti-bovine mastitis drug-resistant pathogenic bacteria specific composite IgY and its preparation
10/17/2012CN102731651A Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
10/17/2012CN102731650A Monoclonal antibody for inhibiting virus from infecting human T lymphocyte
10/17/2012CN102731649A Chicken-derived single-chain antibody against Newcastle disease virus, its preparation method and application
10/17/2012CN102731629A Antibacterial peptide and application thereof
10/17/2012CN102731626A Cyclopeptide and its medicinal application
10/17/2012CN102731623A Murine original monoclonal antibody 3D8 identified hantaan virus glycoprotein neutralizing epitope peptide and application thereof
10/17/2012CN102731617A Hantaan virus glucoprotein specific T cell epitope peptide and application thereof
10/17/2012CN102731594A New flavonoid glycoside, derivatives thereof, preparation method and medical application thereof
10/17/2012CN102731591A Anti-tumor anti-virus compound, preparation method and application thereof
10/17/2012CN102731585A New active clindamycin phosphate compound and medicinal composition thereof
10/17/2012CN102731571A Novel crystalline s-(-)-ornidazole phosphate disodium hydrate and application thereof
10/17/2012CN102731568A Compound for HIV-1 (human immunodeficiency virus type 1) specifically targeted antiviral AIDS (acquired immune deficiency syndrome) treatment medicament
10/17/2012CN102731532A Cefotetan disodium compound as well as preparation method and medicinal composition thereof
10/17/2012CN102731530A Novel cephalosporin compound and its synthesis method and use
10/17/2012CN102731521A Chromone compound in aromatic tobaccos, preparation method and application thereof
10/17/2012CN102731507A Tebipenem crystal forms, their preparation method and application in preparation of medicines
10/17/2012CN102731410A Preparation and application of pyridazine human immunodeficiency virus (HIV)-1 reverse transcriptase inhibitor
10/17/2012CN102731405A Photodynamic treatment medicament, medical composition and preparation method thereof
10/17/2012CN102731394A Substituted quinoline-2-formaldehyde-phenylhydrazone derivative, and preparation method and application thereof
10/17/2012CN102731365A Hericium erinaceum biological micro-molecules for inhibiting helicobacter pylori and use of the hericium erinaceum biological micro-molecules in treatment of digestive tract diseases
10/17/2012CN102731344A Hydrazine nitrile cathepsin inhibitors with different P<3> structures, and application thereof
10/17/2012CN102731338A Physiological cooling compositions containing highly purified ethyl ester of n-[[5-methyl-2-(1-methylethyl)cyclohexyl)carbonyl]glycine
10/17/2012CN102731301A Thymol ester derivatives, its preparation method and application thereof
10/17/2012CN102731296A Rosmarinic acid derivative, its preparation method, and its application in preparation of antitubercular medicines
10/17/2012CN102731291A Synthesis of 6-acetylenic acid compound and its application in antifungal field
10/17/2012CN102727908A Oral gene vaccine for enterovirus, and preparation and application thereof
10/17/2012CN102727904A Heat resisting protective agent of bivalent live vaccine against highly pathogenic porcine reproductive and respiratory syndrome-pseudorabies and preparation method thereof
10/17/2012CN102727903A Heatproof lyophilized protective agent for live vaccine JXA1-R strain for highly pathogenic porcine reproductive and respiratory syndrome and method for preparing the same
10/17/2012CN102727889A Application of specific antibodies in preparation of biological products for controlling virus infection based on virus acceptor binding site selection
10/17/2012CN102727886A Preparation method of immunostimulatory injection for livestock
10/17/2012CN102727885A Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
10/17/2012CN102727884A Combined live vaccine against porcine reproductive and respiratory syndrome and pseudorabies, and preparation method thereof
10/17/2012CN102727883A Combined live vaccine against porcine reproductive and respiratory syndrome and swine fever, and application thereof
10/17/2012CN102727882A Combined live vaccine against porcine reproductive and respiratory syndrome, swine fever and pseudorabies, and preparation method thereof
10/17/2012CN102727881A Highly pathogenic porcine reproductive and respiratory syndrome JXAl-R strain- porcine parvovirus disease bigeminal live vaccine and preparation method and application thereof
10/17/2012CN102727880A Genetically engineered swine influenza virus and uses thereof
10/17/2012CN102727879A Spinner bottle production method of inactivated singapore grouper iridovirus (SGIV) vaccine
10/17/2012CN102727878A Preparation method of porcine reproductive and respiratory syndrome inactivated vaccine (NVDC-JXA1 strain) by bioreactor and application thereof
1 ... 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 ... 1798